BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18239749)

  • 41. [Systemic use of corticoids in rheumatoid arthritis].
    Dürrigl T
    Reumatizam; 1974; 21(4):127-34. PubMed ID: 4411079
    [No Abstract]   [Full Text] [Related]  

  • 42. Anti-tumour necrosis factor {alpha} therapy in patients with rheumatoid arthritis results in a significant and long-lasting decrease of concomitant glucocorticoid treatment.
    Naumann L; Huscher D; Detert J; Spengler M; Burmester GR; Buttgereit F
    Ann Rheum Dis; 2009 Dec; 68(12):1934-6. PubMed ID: 19910303
    [No Abstract]   [Full Text] [Related]  

  • 43. Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al.
    van Tuyl LH; Lems WF; Voskuyl AE; Dijkmans BA; Boers M; Kerstens PJ
    Arthritis Rheum; 2009 Jan; 61(1):141-2; author reply 141-2. PubMed ID: 19116962
    [No Abstract]   [Full Text] [Related]  

  • 44. [Calcium and vitamin D preparations in steroid osteoporosis in patients with rheumatoid arthritis].
    Bazhenov AN; Plesovskaia IV; Iliushina LV
    Ter Arkh; 2007; 79(5):89-92. PubMed ID: 17672084
    [No Abstract]   [Full Text] [Related]  

  • 45. [Intra-articular treatment of rheumatoid arthritis].
    Henneberg Z
    Reumatizam; 1974; 21(4):135-8. PubMed ID: 4409900
    [No Abstract]   [Full Text] [Related]  

  • 46. [Glucocorticoids in rheumatology].
    Sörensen H
    Med Klin (Munich); 1993 Jan; 88 Suppl 1():13-4. PubMed ID: 8437534
    [No Abstract]   [Full Text] [Related]  

  • 47. Steroids for rheumatoid arthritis: the honeymoon revisited (once again).
    Caplan L; Russell AS; Wolfe F
    J Rheumatol; 2005 Oct; 32(10):1863-5. PubMed ID: 16206335
    [No Abstract]   [Full Text] [Related]  

  • 48. Dilemmas of low dosage glucocorticoid treatment in rheumatoid arthritis: considerations of timing.
    Masi AT; Chrousos GP
    Ann Rheum Dis; 1997 Jan; 56(1):1-4. PubMed ID: 9059132
    [No Abstract]   [Full Text] [Related]  

  • 49. [Papilledema during corticoid therapy].
    Constantinides G; Christiaens JL; Guilbert F
    Bull Soc Ophtalmol Fr; 1972 Nov; 72(11):1139-40. PubMed ID: 4667838
    [No Abstract]   [Full Text] [Related]  

  • 50. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha.
    Conti F; Ceccarelli F; Priori R; Iagnocco A; Signore A; Valesini G
    Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158
    [No Abstract]   [Full Text] [Related]  

  • 51. [Influence of glucocorticosteroid on defence mechanism in tuberculous infection].
    Shima K; Fududa Y; Ando M; Tateishi T; Tokunaga K
    Kekkaku; 1975 Jan; 50(1):9-16. PubMed ID: 1127846
    [No Abstract]   [Full Text] [Related]  

  • 52. Glucocorticoid therapy in rheumatoid arthritis: intra-articular injections versus systemic administration.
    Harris ED
    Nat Clin Pract Rheumatol; 2006 Apr; 2(4):184-5. PubMed ID: 16932681
    [No Abstract]   [Full Text] [Related]  

  • 53. [What is the status of intra-articular corticoid therapy in the current treatment of rheumatoid arthritis?].
    Krause A
    Internist (Berl); 1993 Dec; 34(12):1156. PubMed ID: 8106212
    [No Abstract]   [Full Text] [Related]  

  • 54. [Benefits and risks of glucocorticoid therapy for the treatment of rheumatoid arthritis and management of glucocorticoid-induced osteoporosis].
    Suzuki Y; Wakabayashi T; Saito E; Yamada C; Suwa A
    Clin Calcium; 2009 Mar; 19(3):404-15. PubMed ID: 19252251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comment on high HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
    Dullaart RP
    Eur J Clin Invest; 2009 Jun; 39(6):533. PubMed ID: 19490063
    [No Abstract]   [Full Text] [Related]  

  • 56. [Arterial thrombosis during corticosteroid therapy].
    Ziprkowski L; Schewach-Millet M; Sandbank M; Mozes M
    Harefuah; 1971 May; 80(10):540-3. PubMed ID: 5158316
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of glucocorticoid treatment on focal and systemic bone loss in rheumatoid arthritis.
    Di Munno O; Delle Sedie A
    J Endocrinol Invest; 2008 Jul; 31(7 Suppl):43-7. PubMed ID: 18791351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral vascular circulation in patients with rheumatoid arthritis influence of papaverine.
    Batterman RC; Jensen G; Jensen L
    Angiology; 1970 Oct; 21(9):612-26. PubMed ID: 5457224
    [No Abstract]   [Full Text] [Related]  

  • 59. [Rheumatoid arthritis and hyperthyroidism. Apropos of the association of rheumatoid arthritis and toxic adenoma].
    Rampon S; Bussière JL; Prin P; Sauvezie B; Missioux D; Doly J; Morin B
    Rev Rhum Mal Osteoartic; 1973; 40(7):503-13. PubMed ID: 4756425
    [No Abstract]   [Full Text] [Related]  

  • 60. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis.
    Hoes JN; Jacobs JW; Verstappen SM; Bijlsma JW; Van der Heijden GJ
    Ann Rheum Dis; 2009 Dec; 68(12):1833-8. PubMed ID: 19066177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.